DNTH — Dianthus Therapeutics Inc

In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Dianthus Therapeutics Inc (DNTH), worth $137.95M combined. Over the quarter 2 opened or added, 3 trimmed or exited.

Hedge fund holders, 2026 Q2

FundValuePortfolio %Change
Polar Capital$99.31M0.28%-5.3%
Emerald$24.16M0.57%NEW
Emerald Mutual$12.77M0.45%NEW
BIT$1.17M0.04%NO CHANGE
Persistent$543.06K0.17%-25.1%

All stocks · Quarterly Trends · Hedge Fund Tracker

Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.